Initiation of warfarin in hospitals.
作者信息
Doi Suhail A R
出版信息
Clin Med Res. 2007 Dec;5(4):207-8. doi: 10.3121/cmr.2007.777.
Abstract
摘要
相似文献
1
Initiation of warfarin in hospitals.医院中华法林的起始使用。
Clin Med Res. 2007 Dec;5(4):207-8. doi: 10.3121/cmr.2007.777.
2
Joint Commission's requirements for warfarin dosing guidelines.联合委员会对华法林剂量指南的要求。
Am J Health Syst Pharm. 2010 Sep 15;67(18):1557. doi: 10.2146/ajhp100204.
3
Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.口服抗凝剂的起始治疗：使用华法林剂量计算图的理论依据。
Semin Vasc Med. 2003 Aug;3(3):255-60. doi: 10.1055/s-2003-44461.
4
Patient factors that influence warfarin dose response.影响华法林剂量反应的患者因素。
J Pharm Pract. 2010 Jun;23(3):194-204. doi: 10.1177/0897190010362177. Epub 2010 May 6.
5
Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.药师管理的住院患者抗凝治疗启动和滴定服务的疗效和安全性。
J Clin Pharm Ther. 2011 Oct;36(5):585-91. doi: 10.1111/j.1365-2710.2010.01216.x. Epub 2010 Nov 12.
6
Prospective assessment of a nomogram for the initiation of oral anticoagulation therapy for outpatient treatment of venous thromboembolism.用于门诊治疗静脉血栓栓塞症启动口服抗凝治疗的列线图的前瞻性评估。
Pathophysiol Haemost Thromb. 2002 May-Jun;32(3):131-3. doi: 10.1159/000065215.
7
Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen.老年内科住院患者华法林治疗的起始：一种安全且准确的方案。
Am J Med. 2005 Feb;118(2):137-42. doi: 10.1016/j.amjmed.2004.07.053.
8
Target-specific oral anticoagulants: should we switch from warfarin?靶向性口服抗凝剂：我们应该停用华法林吗？
Tex Heart Inst J. 2015 Jun 1;42(3):229-33. doi: 10.14503/THIJ-15-5065. eCollection 2015 Jun.
9
Fluctuations of international normalized ratio in patients treated with oral warfarin therapy in Sneddon's syndrome.
Eur J Neurol. 1999 Mar;6(2):255. doi: 10.1111/j.1468-1331.1999.tb00023.x.
10
[Oral anticoagulants treatment of thrombosis].[口服抗凝剂治疗血栓形成]
Nihon Naika Gakkai Zasshi. 1995 Sep 10;84(9):1523-7.
本文引用的文献
1
Evaluation of genetic factors for warfarin dose prediction.用于华法林剂量预测的遗传因素评估。
Clin Med Res. 2007 Mar;5(1):8-16. doi: 10.3121/cmr.2007.724.
2
Pharmacodynamic optimization of warfarin therapy II.华法林治疗的药效学优化II。
Am J Ther. 2001 Jan-Feb;8(1):41-7. doi: 10.1097/00045391-200101000-00008.
3
Pharmacodynamic optimization of warfarin therapy.华法林治疗的药效学优化
Clin Pharmacol Ther. 1994 May;55(5):597-601. doi: 10.1038/clpt.1994.74.
4
Therapeutic control of anticoagulant treatment.抗凝治疗的治疗性控制
Br Med J (Clin Res Ed). 1982 Mar 6;284(6317):702-4. doi: 10.1136/bmj.284.6317.702.
5
Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.华法林的临床药代动力学与药效学。理解剂量效应关系。
Clin Pharmacokinet. 1986 Nov-Dec;11(6):483-504. doi: 10.2165/00003088-198611060-00005.
6
Therapeutic control of oral anticoagulant treatment in The Netherlands.荷兰口服抗凝治疗的治疗控制
Am J Clin Pathol. 1988 Dec;90(6):685-90. doi: 10.1093/ajcp/90.6.685.
Zotero 插件